Description
Randomized Phase II/IIITrial of Radiation With High-Dose Cisplatin (100 mg/m2) Every Three WeeksVersus Radiation With Low-Dose Weekly Cisplatin (40 mg/m2) for Patients WithLocoregionally Advanced Squamous Cell Carcinoma of the Head and Neck